I propose to take Questions Nos. 1748, 1761 and 1816 together.
The immunisation programme in Ireland is based on the advice of the National Immunisation Advisory Committee (NIAC). The Committee makes recommendations to my Department based on the prevalence of the relevant disease in Ireland and international best practices in relation to immunisation.
The NIAC develops guidance for the use of vaccines in Ireland which is contained in the Immunisation Guidelines. These guidelines are continuously updated and include guidance on all new vaccines as they are approved for use in Ireland
The Immunisation Guidelines state that if there is a precaution to a booster mRNA vaccine, consideration can be given to boosting with an authorised non-mRNA vaccine following an individual benefit-risk assessment.
As this is a service matter, I have asked the Health Service Executive to respond to the deputy directly, as soon as possible.